000			01939 a2200505 4500
005			20250517224257.0
264		0	_c20190116
008			201901s 0 0 eng d
022			_a1178-2005
024	7		_a10.2147/COPD.S166455 _2doi
040			_aNLM _beng _cNLM
100	1		_aReisner, Colin
245	0	0	_aEfficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD. _h[electronic resource]
260			_bInternational journal of chronic obstructive pulmonary disease _c2018
300			_a1965-1977 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
650	0	4	_aAdministration, Inhalation
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aArea Under Curve
650	0	4	_aBronchodilator Agents _xadministration & dosage
650	0	4	_aCross-Over Studies
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aForced Expiratory Volume
650	0	4	_aFormoterol Fumarate _xadministration & dosage
650	0	4	_aGlycopyrrolate _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMetered Dose Inhalers
650	0	4	_aMiddle Aged
650	0	4	_aMuscarinic Antagonists _xadministration & dosage
650	0	4	_aNutrition Surveys
650	0	4	_aPulmonary Disease, Chronic Obstructive _xdrug therapy
650	0	4	_aReproducibility of Results
650	0	4	_aSeverity of Illness Index
700	1		_aPearle, James
700	1		_aKerwin, Edward M
700	1		_aRose, Earl St
700	1		_aDarken, Patrick
773	0		_tInternational journal of chronic obstructive pulmonary disease _gvol. 13 _gp. 1965-1977
856	4	0	_uhttps://doi.org/10.2147/COPD.S166455 _zAvailable from publisher's website
999			_c28577465 _d28577465